51³ΙΘΛΆ―Βώ

Meeting Coverage

ASCO Future Focus: Renal Cell Carcinoma

Future Focus from the American Society of Clinical Oncology

Impact of TKI Combinations in Front-Line Treatment of RCC

Kathryn Beckermann on enthusiasm about updated survival data for patients with metastatic disease

image

Latest ASCO Future Focus: Renal Cell Carcinoma Meeting Coverage

What to Expect at ASCO 2024 in the Kidney Cancer Space

Pavlos Msaouel, MD, PhD, offers a brief summary of what he hopes to see at next year's meeting

July 6, 2023
Combination Therapies Come of Age in Kidney Cancer

David Braun hopes this is an inflection point for getting long-term durable responses

June 28, 2023
What Does the Evidence Say About Immunotherapy Rechallenge in RCC?

Kathryn Beckermann, MD, shares insights on the evolving treatment landscape in metastatic RCC

June 21, 2023

Latest Oncology/Hematology Meeting Coverage